Hepatitis C knowledge among new injection drug users

References

• Alter MJ, Kruszon-Moran D, Nianan OV, McQuillan GM, Gao F, Moyer LA, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. New England Journal of Medicine 1999; 341: 556–562
   PubMed Web of Science ®Google Scholar
• Bourgois P. The moral economies of homeless heroin addicts: Confronting ethnography, HIV risk and everyday violence in San Francisco shooting encampments. Substance Use and Misuse 1998; 33: 2323–2351
   PubMed Web of Science ®Google Scholar
• Carey J, Perlman DC, Friedmann P, Kaplan WM, Nugent A, Deutscher M, et al. Knowledge of hepatitis among active drug injectors at a syringe exchange program. Journal of Substance Abuse Treatment 2005; 29: 47–53
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control, and Prevention. Viral hepatitis C fact sheet. Centers for Disease Control and Prevention, Atlanta 2006
   Google Scholar
• Centers for Disease Control, and Prevention (2006). Hepatitis C: An epidemic for everyone. Retrieved February 10, 2009, from http://www.epidemic.org/theFacts/theEpidemic
   Google Scholar
• Connors MM. Stories of pain and the problem of AIDS prevention: Injection drug withdrawal and its effect on risk behavior. Medical Anthropology Quarterly 1994; 8: 47–68
   Web of Science ®Google Scholar
• Copeland L. The drug user's identity and how it relates to being hepatitis C antibody positive: A qualitative study. Drugs: Education, Prevention and Policy 2004; 11: 129–147
   Web of Science ®Google Scholar
• Crofts N, Jolley D, van Beek I, Wodak A. Epidemiology of hepatitis C virus infection among injecting drug users in Australia. Journal of Epidemiology and Community Health 1997; 51: 692–697
   PubMed Web of Science ®Google Scholar
• Danta, M., van de Laar, T., Brown, D., Pybus, O., Bhagani, S., Vogel, M. et al. (2007, July). Evidence of international transmission of HCV in pan-European HIV-positive men who have sex with men (MSM). Paper presented at 4th International AIDS Society Conference, Sidney, Australia
   Google Scholar
• Davis M, Rhodes T. Beyond prevention? Injecting drug user narratives about hepatitis C. International Journal of Drug Policy 2003; 15: 123–131
   Google Scholar
• Davis M, Rhodes T, Martin A. Preventing hepatitis C: ‘Common sense’, ‘the bug’ and other perspectives from the risk narratives of people who inject drugs. Social Science & Medicine 2004; 59: 1807–1818
   PubMed Web of Science ®Google Scholar
• Des Jarlais DC, Friedman SR. AIDS and IV drug use. Science 1989; 245: 578–579
   PubMed Web of Science ®Google Scholar
• Des Jarlais DC, Friedman SR. Variability in the incidence of human immunodeficiency virus, hepatitis B virus and hepatitis C virus infection among young injection drug users in New York City. American Journal of Epidemiology 2003; 157: 467–471
   PubMed Web of Science ®Google Scholar
• Evans M, Stotts AL, Graham S, Schmitz J, Grabowski J. Hepatitis C knowledge assessment and counseling within the context of substance abuse treatment. Addictive Disorders & Their Treatment 2004; 3: 18–26
   Google Scholar
• Fraser S. ‘It's your life!’: injecting drug users, individual responsibility and hepatitis C prevention. Health: An interdisciplinary Journal for the Social Study of Health, Illness and Medicine 2004; 8: 199–221
   Web of Science ®Google Scholar
• Fraser S, Treloar C. ‘Spoiled identity’ in hepatitis C infection: The binary logic of despair. Critical Public Health 2006; 16: 99–110
   Google Scholar
• Freeman AJ, Dore GJ, Law MG, Thorpe M, Von Overbeck J, Lloyd AR, et al. Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology 2001; 34: 809–816
   PubMed Web of Science ®Google Scholar
• Galvin R. Disturbing notions of chronic illness and individual responsibility: Towards a genealogy of morals. Health: An interdisciplinary Journal for the Social Study of Health, Illness and Medicine 2002; 6: 107–137
   Web of Science ®Google Scholar
• Garfein RS, Doherty MC, Monterroso ER, Thomas DL, Nelson KE, Vlahov D. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1998; 18: S11–19
   PubMed Web of Science ®Google Scholar
• Ghosn J, Deveau C, Goujard C, Saichi N, Galimand J, Nagy Z, et al. Increase in hepatitis C virus incidence in HIV-1-infected patients followed up since primary infection. Sexually Transmitted Infections 2006; 82: 458–460
   Web of Science ®Google Scholar
• Giraudon I, Ruf M, Maguire H, Charlett A, Ncube F, Turner J, et al. Increase in diagnosed newly acquired hepatitis C in HIV-positive men who have sex with men across London and Brighton, 2002–2006: Is this an outbreak. Sexually Transmitted Infections 2008; 84: 111–115
   PubMed Web of Science ®Google Scholar
• Grebely J, Genoway K, Raffa JD, Dhadwal G, Rajan T, Showler G, et al. Barriers associated with the treatment of hepatitis C virus infection among illicit drug users. Drug and alcohol Dependence 2008; 93: 141–147
   PubMed Web of Science ®Google Scholar
• Hagan H, Thiede H, Des Jarlais DC. Hepatitis C virus infection among injection drug users: Survival analysis of time to seroconversion. Epidemiology 2004; 15: 543–549
   PubMed Web of Science ®Google Scholar
• Hagan H, Thiede H, Weiss NS, Hopkins SG, Duchin JS, Alexander ER. Sharing of drug preparation equipment as a risk factor for hepatitis C. American Journal of Public Health 2001; 91: 42–46
   PubMed Web of Science ®Google Scholar
• Hahn JA, Page-Shafer K, Lum PJ, Bourgois P, Stein E, Evans JL, et al. Hepatitis C seroconversion among young injection drug users: Relationships and risks. Journal of Infectious Diseases 2002; 186: 1558–1564
   PubMed Web of Science ®Google Scholar
• Hahn JA, Page-Shafer K, Lum PJ, Ochoa K, Moss AR. Hepatitis C infection and needle exchange use among young drug injection drug users in San Francisco. Hepatology 2001; 34: 180–187
   PubMed Web of Science ®Google Scholar
• Heimer R, Clair S, Grau LE, Bluthenhal RN, Marshall PA, Singer M. Hepatitis-associated knowledge is low and risks are high among HIV-aware injection drug users in three US cities. Addiction 2002; 97: 1277–1287
   PubMed Web of Science ®Google Scholar
• Koester S, Glanz J, Baro A. Drug sharing among heroin networks: Implications for HIV and hepatitis B and C prevention. AIDS and Behavior 2005; 9: 27–39
   PubMed Web of Science ®Google Scholar
• Kwiatkowski CF, Fortuin Corsi K, Booth RE. The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users. Addiction 2002; 97: 1289–1294
   PubMed Web of Science ®Google Scholar
• Limburg W. National history, treatment and prevention of hepatitis C in injecting drug users. Hepatitis C and injecting drug use: Impact, costs and policy options, JC Jager, W Limburg, M Kretzschmar, MJ Postma, L Wiessing. European Monitoring Centre for Drugs And Drug Addiction, Lisbon 2004; 21–40
   Google Scholar
• Maher L, Jalalduin B, Chant KG, Jayasuriya R, Sladden T, Kaldor JM, et al. Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia. Addiction 2006; 101: 1499–1508
   PubMed Web of Science ®Google Scholar
• Mansson AS, Moestrup T, Nordenfelt E, Widell A. Continued transmission of hepatitis B and C viruses, but no transmission of human immunodeficiency virus among intravenous drug users participating in a syringe/needle exchange program. Scandinavian Journal of Infectious Disease 2000; 32: 253–258
   PubMed Web of Science ®Google Scholar
• Matthews GV, Hellard M, Kaldor J, Lloyd A, Dore GJ. Further evidence of HCV sexual transmission among HIV-positive men who sex with men: Response to Danta et al. AIDS 2007; 21: 2112–2113
   PubMed Web of Science ®Google Scholar
• Pohl A, Behling C, Oliver D, Kilani M, Monson P, Hasssanein T. Recommendations from the National Institutes of Health consensus development conference statement: Management of hepatitis C. Hepatology 2002; 36: 1039
   PubMedGoogle Scholar
• Rhodes T, Cusick L. Accounting for unprotected sex: stories of agency and acceptability. Social Science and Medicine 2002; 55: 211–266
   PubMed Web of Science ®Google Scholar
• Rhodes T, Davis D, Judd A. Hepatitis C and its risk management among drug injectors in London: Renewing harm reduction in the context of uncertainty. Addiction 2004; 99: 621–633
   PubMed Web of Science ®Google Scholar
• Rhodes T, Zihic B, Prodanovic A, Kuneski E, Bernays S. Hygiene and uncertainty in qualitative accounts of hepatitis C transmission among drug injectors in Siberia. Social Science & Medicine 2008; 66: 1437–1447
   PubMed Web of Science ®Google Scholar
• Rosenblum A, Nuttbrock L, McQuistion H, Magura S, Joseph H. Hepatitis C and substance use in a sample of homeless people in New York City. Journal of Addictive Diseases 2001; 20: 15–25
   PubMed Web of Science ®Google Scholar
• Roy K, Hay G, Andragetti R, Taylor A, Goldberg D, Wiessing L. Monitoring hepatitis C infection among injecting drug user in the European Union: A review of the literature. Epidemiology and Infection 2002; 129: 577–585
   PubMed Web of Science ®Google Scholar
• Roy E, Nonn E, Haley N, Cox J. Hepatitis C meanings and preventive strategies among street-involved young injection drug users in Montreal. International Journal of Drug Policy 2007; 18: 397–405
   PubMed Web of Science ®Google Scholar
• Smyth BP, McMahon J, O’Connor JJ, Ryan J. Knowledge regarding Hepatitis C among injecting drug users. Drugs: Education, Prevention and Policy 1999; 6: 257–264
   Web of Science ®Google Scholar
• Stark K, Muller R, Bienzle U, Guggenmoos-Holzmann I. Frontloading: A risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin. AIDS 1996; 10: 311–317
   PubMed Web of Science ®Google Scholar
• Stein MD, Maksad J, Clarke J. Hepatitis C disease among injection drug users: Knowledge, perceived risk and willingness to receive treatment. Drug and Alcohol Dependence 2001; 61: 211–215
   PubMed Web of Science ®Google Scholar
• Strauss AL. Qualitative analysis for social scientists. Cambridge University Press, Cambridge, UK 1987
   Google Scholar
• Strauss AL, Corbin J. Basics of qualitative research: Grounded theory procedures and techniques. Sage, Newbury Park, CA 1990
   Google Scholar
• Tahan V, Karaca C, Yildirim B, Bozbas A, Ozaras, R., Demir K, et al. Sexual transmission of HCV between spouses. American Journal of Gastroenterology 2005; 100: 821–824
   PubMed Web of Science ®Google Scholar
• Taylor A, Goldberg D, Hutchinson S, Cameron S, Gore S, McMenamin J, et al. Prevalence of hepatitis C virus infection among injecting drug users in Glasgow 1990–1996: Are current harm reduction strategies working?. Journal of Infection 2000; 40: 176–183
   PubMed Web of Science ®Google Scholar
• Thorpe LE, Ouellet LJ, Levy JR, Williams IT, Monterroso ER. Hepatitis C virus infection: Prevalence, risk factors, and prevention opportunities among young drug users in Chicago, 1997–1999. Journal of Infectious Diseases 2000; 182: 1588–1594
   PubMed Web of Science ®Google Scholar
• Tortu S, McMahon JM, Pouget ER, Hamid R. Sharing of noninjection drug-use implements as a risk factor for hepatitis C. Substance Use and Misuse 2004; 39: 211–224
   PubMed Web of Science ®Google Scholar
• Treloar C, Abelson J. Information exchange among injecting drug users: A role for an expanded peer education workforce. International Journal of Drug Policy 2005; 16: 46–53
   Web of Science ®Google Scholar
• Vandelli C, Renzo F, Romano L, Tisminetzky S, De Palma M, Stroffolini T, et al. Lack of evidence of sexual transmission of hepatitis C among monogamous couples: Results of a 10-year prospective follow-up study. American Journal of Gastroenterology 2004; 99: 855–859
   PubMed Web of Science ®Google Scholar
• Villano SA, Nelson KE, Vlahov D, Purcell RD, Saah AJ, Thomas DL. Hepatitis A among homosexual men and injection drug users: More evidence for vaccination. Clinical Infectious Diseases 1997; 25: 726–728
   PubMed Web of Science ®Google Scholar
• Wozniak L, Prakash M, Taylor M, Wild TC. Everybody's got it, but … : situational and strategic participation in normalized HCV discourse among injection drug users in Edmonton, Canada. International Journal of Drug Policy 2007; 18: 388–396
   PubMed Web of Science ®Google Scholar
• Wright N, Tompkins C, Jones L. Exploring risk perception and behavior of homeless injecting drug users diagnosed with hepatitis C. Health and Social Care in the Community 2005; 13: 75–83
   PubMed Web of Science ®Google Scholar